News & Discoveries

January 31, 2023

20-Year Study Shows Advances in Care Have Improved Outcomes for Newborns with Congenital Heart Disease (CHD) Increasing a newborn’s blood pressure after heart surgery may reduce brain injuries and increase survival for infants.

January 30, 2023

UCSF-Led Study Shows Benzos, Antidepressants, Ambien May Impact CognitionSleep medications may increase risk of dementia for white people, though the type and amount of medication may also explain the higher probability.

January 12, 2023

On the operating table and inside the lab of a rising star in cancer neurosurgery.On the operating table and inside the lab of a rising star in cancer neurosurgery.

January 12, 2023

Could psychedelics become mainstream medicines?Could psychedelics become mainstream medicines?

January 04, 2023

UCSF-Led Study Shows Extensive Resection Results in Longer Survival for Glioma PatientsResecting brain tumors called gliomas as much as possible soon after diagnosis offers a distinct survival advantage when looking at the disease trajectory 10 years later, find UCSF researchers.

January 03, 2023

Lecanemab, Donanemab, Drug-Free Strategies Emerge as New Weapons Against DementiaUCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.

December 28, 2022
Creative Minds Care is partnering with UCSF Weill Institute for Neurosciences to create a fellowship of $75,000 to support a UCSF neuroscience scholar performing research in neurodegenerative diseases.
December 20, 2022

UCSF Researchers Identify the Cellular Source of Recurrent GliomaThrough decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.

December 20, 2022

While we sleep, our brains process our daily actions to create motor memory, which makes physical acts such as throwing a basketball subconscious.

November 30, 2022

38 UCSF researchers rank in the top 1 percent for impact in their fields, according to a new analysis of research citations by science and intellectual property company Clarivate.

Pages